Aries Wealth Management Has $2.20 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aries Wealth Management trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,341 shares of the healthcare conglomerate’s stock after selling 60 shares during the period. Aries Wealth Management’s holdings in UnitedHealth Group were worth $2,196,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Friedenthal Financial acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $51,000. DecisionPoint Financial LLC raised its stake in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. Finally, Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on UNH shares. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $629.32.

Get Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE UNH opened at $531.31 on Friday. The stock has a 50-day moving average price of $524.58 and a two-hundred day moving average price of $563.71. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $488.95 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.